A Prospective Longitudinal Study of the Effects of Eslicarbazepine Acetate Treatment on Bone Density and Metabolism in Patients with Focal-Onset Epilepsy Martin HirschIlka ImmischAndreas Schulze-Bonhage Original Research Article Open access 03 November 2023 Pages: 973 - 980
Solriamfetol: A Review in Excessive Daytime Sleepiness Associated with Narcolepsy and Obstructive Sleep Apnoea Sheridan M. Hoy Adis Drug Evaluation 17 October 2023 Pages: 1009 - 1020
Dextromethorphan-Bupropion for the Treatment of Depression: A Systematic Review of Efficacy and Safety in Clinical Trials Dania AkbarTaeho Greg RheeRoger S. McIntyre Systematic Review 04 October 2023 Pages: 867 - 881
Third-Generation Antiseizure Medication in the Treatment of Benzodiazepine-Refractory Status Epilepticus in Poststroke Epilepsy: A Retrospective Observational Register-Based Study Yaroslav WinterKatharina SandnerSergiu Groppa Original Research Article Open access 02 October 2023 Pages: 929 - 936
Stopping Disease-Modifying Treatments in Multiple Sclerosis: A Systematic Review and Meta-Analysis of Real-World Studies Luca ProsperiniShalom HaggiagClaudio Gasperini Systematic Review 23 September 2023 Pages: 915 - 927
Effectiveness and Tolerability of 12-Month Brivaracetam in the Real World: EXPERIENCE, an International Pooled Analysis of Individual Patient Records Vicente VillanuevaCédric LaloyauxBernhard J. Steinhoff Original Research Article Open access 09 September 2023 Pages: 819 - 835
Network Meta-analysis of Different Treatments for Vestibular Migraine Jiann-Jy ChenBing-Syuan ZengPing-Tao Tseng Original Research Article Open access 07 September 2023 Pages: 837 - 847
Assisted Reproductive Technology and Disease Management in Infertile Women with Multiple Sclerosis Maddalena SparacoLuigi CarboneSimona Bonavita Review Article Open access 07 September 2023 Pages: 849 - 866
Authors’ Reply to Pande et al. Comment on “Extended-Release Viloxazine Compared to Atomoxetine for Attention Deficit Hyperactivity Disorder” Maxwell Z. PriceRichard L. Price Letter to the editor Open access 01 September 2023 Pages: 939 - 940
Comment on: “Extended‑Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder” Uday PandeNitin R. GaikwadAlok Singh Letter to the Editor 01 September 2023 Pages: 937 - 938
Over the Counter Supplements for Memory: A Review of Available Evidence Haley HersantSean HeGeorge Grossberg Review Article 21 August 2023 Pages: 797 - 817
New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: II. Treatments in Clinical Development Emilio PeruccaH. Steve WhiteMeir Bialer Review Article Open access 21 August 2023 Pages: 781 - 795
New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: I. Role of GABA as a Modulator of Seizure Activity and Recently Approved Medications Acting on the GABA System Emilio PeruccaMeir BialerH. Steve White Review Article Open access 21 August 2023 Pages: 755 - 779
Lysergic Acid Diethylamide (LSD) for the Treatment of Anxiety Disorders: Preclinical and Clinical Evidence Antonio InserraAlexandre PiotGabriella Gobbi Leading Article 21 August 2023 Pages: 733 - 754
Efficacy and Safety of Five Broad-Spectrum Antiseizure Medications for Adjunctive Treatment of Refractory Epilepsy: A Systematic Review and Network Meta-analysis Hecheng WangHaoran WangYanshuo Han Systematic Review 17 August 2023 Pages: 883 - 913
Efficacy and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Who Completed a Second Induction Period: Analysis of the Ongoing SUSTAIN-3 Study Meredith CastroSamuel T. WilkinsonPatricia Cabrera Original Research Article Open access 09 August 2023 Pages: 715 - 723
GABA-ergic Modulators: New Therapeutic Approaches to Premenstrual Dysphoric Disorder Christopher Sikes-KeilpDavid R. Rubinow Review Article 05 August 2023 Pages: 679 - 693
The Utilization of Low Dose Naltrexone for Chronic Pain Salomon PoliwodaBryant NossOmar Viswanath Current Opinion 28 July 2023 Pages: 663 - 670
Effectiveness and Safety of Switching from Oral Antipsychotics to Once-Monthly Paliperidone Palmitate (PP1M) in the Management of Schizophrenia: A Systematic Review and Meta-Analysis Qian LiXin LiTianmei Si Systematic Review Open access 25 July 2023 Pages: 695 - 713
Number, Duration, and Distribution of Wake Bouts in Patients with Insomnia Disorder: Effect of Daridorexant and Zolpidem Tobias Di MarcoThomas E. ScammellYves Dauvilliers Original Research Article Open access 21 July 2023 Pages: 639 - 653
Amyloid-Lowering Monoclonal Antibodies for the Treatment of Early Alzheimer’s Disease Solana LeisherAdriana BohorquezMichael S. Rafii Review Article Open access 20 July 2023 Pages: 671 - 677
Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in Schizophrenia Jonathan M. MeyerChristoph U. Correll Leading Article Open access 20 July 2023 Pages: 545 - 570
Acute Valproate-Induced Encephalopathy in Status Epilepticus: A Registry-Based Assessment Valentin LoserJan NovyAndrea O. Rossetti Original Research Article Open access 19 July 2023 Pages: 725 - 731
Extended-Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder Maxwell Z. PriceRichard L. Price Original Research Article Open access 10 July 2023 Pages: 655 - 660
Correction to: Rimegepant: A Review in the Acute Treatment and Preventive Treatment of Migraine Hannah A. Blair Correction Open access 04 July 2023 Pages: 661 - 661
The Serotonin 1A (5-HT1A) Receptor as a Pharmacological Target in Depression Alexander L. W. SmithCatherine J. HarmerSusannah E. Murphy Review Article 29 June 2023 Pages: 571 - 585
Turning the Spotlight to Cholinergic Pharmacotherapy of the Human Language System Guadalupe DávilaMaría José Torres-PriorisMarcelo L. Berthier Review Article Open access 21 June 2023 Pages: 599 - 637
Clonazepam Loading Dose in Status Epilepticus: Is More Always Better? Jennifer D’AntoIsabelle BeuchatJan Novy Original Research Article Open access 08 June 2023 Pages: 523 - 529
Adverse Event Profiles of Antiseizure Medications and the Impact of Coadministration on Drug Tolerability in Adults with Epilepsy Laurent M. WillemsMilena van der GotenAdam Strzelczyk Original Research Article Open access 04 June 2023 Pages: 531 - 544
BRAF Mutations in CNS Tumors—Prognostic Markers and Therapeutic Targets Thiago P. MunizWarren P. Mason Review Article 02 June 2023 Pages: 587 - 598
Calcitonin in the Treatment of Phantom Limb Pain: A Systematic Review Johannes NeumüllerKordula Lang-IllievichHelmar Bornemann-Cimenti Systematic Review Open access 01 June 2023 Pages: 513 - 521
Early Non-Response to Antipsychotic Treatment in Schizophrenia: A Systematic Review and Meta-Analysis of Evidence-Based Management Options Jose M. RubioDaniel GuinartChristoph U. Correll Systematic Review 01 June 2023 Pages: 499 - 512
Pharmacological Management of Borderline Personality Disorder and Common Comorbidities Juan C. PascualLaia AriasJoaquim Soler Current Opinion Open access 31 May 2023 Pages: 489 - 497
A Retrospective Real-Life Multicenter Study on Concurrent Oral Preventive Treatments in Patients with Chronic Migraine Treated with OnabotulinumtoxinA Lucas Hendrik OvereemRaffaele OrnelloDaniele Martinelli Original Research Article Open access 22 May 2023 Pages: 453 - 465
New Pharmacological Approaches to the Management of Premenstrual Dysphoric Disorder Inger Sundström-PoromaaErika Comasco Leading Article Open access 12 May 2023 Pages: 371 - 379
Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders Dicson S. MalarPremrutai ThitilertdechaJames M. Brimson Review Article 11 May 2023 Pages: 399 - 440
Nonstimulant Medications for Attention-Deficit/Hyperactivity Disorder (ADHD) in Adults: Systematic Review and Meta-analysis Nevena V. RadonjićAlessio BellatoStephen V. Faraone Systematic Review 11 May 2023 Pages: 381 - 397
Matching-Adjusted Indirect Comparisons of Diroximel Fumarate, Ponesimod, and Teriflunomide for Relapsing Multiple Sclerosis Tammy JiangTjalf ZiemssenMark S. Freedman Original Research Article 08 May 2023 Pages: 441 - 452
Andexanet Alfa to Reverse the Effect of Factor Xa Inhibitors in Intracranial Hemorrhage Senta FrolJanja Pretnar OblakPawel Kermer Leading Article 03 May 2023 Pages: 477 - 487
Idiopathic Hypersomnia: Neurobiology, Diagnosis, and Management Anne Marie MorseSreelatha Naik Review Article 18 April 2023 Pages: 305 - 322
Correction to: Efgartigimod Alfa in Generalised Myasthenia Gravis: A Profile of Its Use Young-A Heo Correction Open access 17 April 2023 Pages: 475 - 475
Pharmacologic Management of Cognitive Disengagement Syndrome (CDS) and Implications for Attention-Deficit/Hyperactivity Disorder (ADHD) Treatment: Emerging Treatments and Recommendations for Future Research Kelsey K. WiggsTanya E. FroehlichStephen P. Becker Leading Article 15 April 2023 Pages: 293 - 304
Efgartigimod Alfa in Generalised Myasthenia Gravis: A Profile of Its Use Young-A Heo Adis Drug Q&A Open access 31 March 2023 Pages: 467 - 473
Sex Differences in Outcomes of Intravenous Thrombolysis in Acute Ischemic Stroke Patients with Preadmission Use of Antiplatelets Roberta NosedaFederico ReaCarlo Walter Cereda Original Research Article Open access 28 March 2023 Pages: 351 - 361
A Randomized, Open-Label, Multiple-Dose, Parallel-Arm, Pivotal Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Aripiprazole 2-Month Long-Acting Injectable in Adults With Schizophrenia or Bipolar I Disorder Matthew HarlinMurat YildirimFrank Larsen Original Research Article Open access 24 March 2023 Pages: 337 - 350
Long-Term Safety and Tolerability During a Clinical Trial and Open-Label Extension of Low-Sodium Oxybate in Participants with Narcolepsy with Cataplexy Richard K. BoganNancy Foldvary-SchaeferMichael J. Thorpy Original Research Article Open access 22 March 2023 Pages: 323 - 335
Satralizumab: A Review in Neuromyelitis Optica Spectrum Disorder Simon FungMatt Shirley Adis Drug Evaluation 18 March 2023 Pages: 363 - 370
Immunoregulatory and/or Anti-inflammatory Agents for the Management of Core and Associated Symptoms in Individuals with Autism Spectrum Disorder: A Narrative Review of Randomized, Placebo-Controlled Trials Gara Arteaga-HenríquezLaura GisbertJosep Antoni Ramos-Quiroga Review Article Open access 13 March 2023 Pages: 215 - 229
Interactions Between Direct Oral Anticoagulants (DOACs) and Antiseizure Medications: Potential Implications on DOAC Treatment Rachel GoldsteinAviya R. JacobsMordechai Muszkat Leading Article 03 March 2023 Pages: 203 - 214
